WALTHAM, Mass.--(BUSINESS WIRE)--Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company announces today that it has purchased the assets of IROC Innocross AG, of Zug, Switzerland. IROC Innocross was the first company to commercialize a cross-linking device for the treatment of keratoconus and other corneal pathologies. To date, IROC Innocross has sold its UV-X devices to more than 1,000 ophthalmologists giving it the largest installed base of cross linking devices in the world.
Help employers find you! Check out all the jobs and post your resume.
